Literature DB >> 18037992

Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition.

Debra F Higgins1, Kuniko Kimura, Wanja M Bernhardt, Nikita Shrimanker, Yasuhiro Akai, Bernd Hohenstein, Yoshihiko Saito, Randall S Johnson, Matthias Kretzler, Clemens D Cohen, Kai-Uwe Eckardt, Masayuki Iwano, Volker H Haase.   

Abstract

Hypoxia has been proposed as an important microenvironmental factor in the development of tissue fibrosis; however, the underlying mechanisms are not well defined. To examine the role of hypoxia-inducible factor-1 (HIF-1), a key mediator of cellular adaptation to hypoxia, in the development of fibrosis in mice, we inactivated Hif-1alpha in primary renal epithelial cells and in proximal tubules of kidneys subjected to unilateral ureteral obstruction (UUO) using Cre-loxP-mediated gene targeting. We found that Hif-1alpha enhanced epithelial-to-mesenchymal transition (EMT) in vitro and induced epithelial cell migration through upregulation of lysyl oxidase genes. Genetic ablation of epithelial Hif-1alpha inhibited the development of tubulointerstitial fibrosis in UUO kidneys, which was associated with decreased interstitial collagen deposition, decreased inflammatory cell infiltration, and a reduction in the number of fibroblast-specific protein-1-expressing (FSP-1-expressing) interstitial cells. Furthermore, we demonstrate that increased renal HIF-1alpha expression is associated with tubulointerstitial injury in patients with chronic kidney disease. Thus, we provide clinical and genetic evidence that activation of HIF-1 signaling in renal epithelial cells is associated with the development of chronic renal disease and may promote fibrogenesis by increasing expression of extracellular matrix-modifying factors and lysyl oxidase genes and by facilitating EMT.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18037992      PMCID: PMC2082142          DOI: 10.1172/JCI30487

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  62 in total

1.  Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells.

Authors:  D E Richard; E Berra; J Pouyssegur
Journal:  J Biol Chem       Date:  2000-09-01       Impact factor: 5.157

2.  Induction of the plasminogen activator inhibitor-1 gene expression by mild hypoxia via a hypoxia response element binding the hypoxia-inducible factor-1 in rat hepatocytes.

Authors:  T Kietzmann; U Roth; K Jungermann
Journal:  Blood       Date:  1999-12-15       Impact factor: 22.113

Review 3.  Is there a common mechanism for the progression of different types of renal diseases other than proteinuria? Towards the unifying theme of chronic hypoxia.

Authors:  L G Fine; D Bandyopadhay; J T Norman
Journal:  Kidney Int Suppl       Date:  2000-04       Impact factor: 10.545

4.  Hypoxia stimulates proximal tubular cell matrix production via a TGF-beta1-independent mechanism.

Authors:  C Orphanides; L G Fine; J T Norman
Journal:  Kidney Int       Date:  1997-09       Impact factor: 10.612

Review 5.  Significance of postglomerular capillaries in the pathogenesis of chronic renal failure.

Authors:  A Bohle; S Mackensen-Haen; M Wehrmann
Journal:  Kidney Blood Press Res       Date:  1996       Impact factor: 2.687

6.  Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth.

Authors:  H E Ryan; M Poloni; W McNulty; D Elson; M Gassmann; J M Arbeit; R S Johnson
Journal:  Cancer Res       Date:  2000-08-01       Impact factor: 12.701

7.  Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy.

Authors:  Maja T Lindenmeyer; Matthias Kretzler; Anissa Boucherot; Silvia Berra; Yoshinari Yasuda; Anna Henger; Felix Eichinger; Stefanie Gaiser; Holger Schmid; Maria P Rastaldi; Robert W Schrier; Detlef Schlöndorff; Clemens D Cohen
Journal:  J Am Soc Nephrol       Date:  2007-05-02       Impact factor: 10.121

8.  Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases.

Authors:  H Zhong; A M De Marzo; E Laughner; M Lim; D A Hilton; D Zagzag; P Buechler; W B Isaacs; G L Semenza; J W Simons
Journal:  Cancer Res       Date:  1999-11-15       Impact factor: 12.701

Review 9.  Oxygen sensing by HIF hydroxylases.

Authors:  Christopher J Schofield; Peter J Ratcliffe
Journal:  Nat Rev Mol Cell Biol       Date:  2004-05       Impact factor: 94.444

10.  Identification and characterization of a fibroblast marker: FSP1.

Authors:  F Strutz; H Okada; C W Lo; T Danoff; R L Carone; J E Tomaszewski; E G Neilson
Journal:  J Cell Biol       Date:  1995-07       Impact factor: 10.539

View more
  390 in total

1.  COMMD1 disrupts HIF-1alpha/beta dimerization and inhibits human tumor cell invasion.

Authors:  Bart van de Sluis; Xicheng Mao; Yali Zhai; Arjan J Groot; Jeroen F Vermeulen; Elsken van der Wall; Paul J van Diest; Marten H Hofker; Cisca Wijmenga; Leo W Klomp; Kathleen R Cho; Eric R Fearon; Marc Vooijs; Ezra Burstein
Journal:  J Clin Invest       Date:  2010-05-10       Impact factor: 14.808

Review 2.  Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities.

Authors:  Swati Bhattacharyya; Jun Wei; John Varga
Journal:  Nat Rev Rheumatol       Date:  2011-10-25       Impact factor: 20.543

Review 3.  Cellular and molecular mechanisms of renal fibrosis.

Authors:  Youhua Liu
Journal:  Nat Rev Nephrol       Date:  2011-10-18       Impact factor: 28.314

4.  Fibroblast expression of an IκB dominant-negative transgene attenuates renal fibrosis.

Authors:  Tsutomu Inoue; Tsuneo Takenaka; Matsuhiko Hayashi; Toshiaki Monkawa; Jun Yoshino; Kouji Shimoda; Eric G Neilson; Hiromichi Suzuki; Hirokazu Okada
Journal:  J Am Soc Nephrol       Date:  2010-09-16       Impact factor: 10.121

5.  Hypoxia-induced phenotypic switch of fibroblasts to myofibroblasts through a matrix metalloproteinase 2/tissue inhibitor of metalloproteinase-mediated pathway: implications for venous neointimal hyperplasia in hemodialysis access.

Authors:  Sanjay Misra; Alex A Fu; Khamal D Misra; Uday M Shergill; Edward B Leof; Debabrata Mukhopadhyay
Journal:  J Vasc Interv Radiol       Date:  2010-06       Impact factor: 3.464

Review 6.  Interactions between nitric oxide and hypoxia-inducible factor signaling pathways in inflammatory disease.

Authors:  Nels Olson; Albert van der Vliet
Journal:  Nitric Oxide       Date:  2011-01-01       Impact factor: 4.427

Review 7.  Renal oxidative stress, oxygenation, and hypertension.

Authors:  Fredrik Palm; Lina Nordquist
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-08-10       Impact factor: 3.619

8.  Cross regulation between hypoxia-inducible transcription factor-1α (HIF-1α) and transforming growth factor (TGF)-ß1 mediates nickel oxide nanoparticles (NiONPs)-induced pulmonary fibrosis.

Authors:  Fenghua Qian; Mindi He; Weixia Duan; Lin Mao; Qian Li; Zhengping Yu; Zhou Zhou; Yong Zhang
Journal:  Am J Transl Res       Date:  2015-11-15       Impact factor: 4.060

Review 9.  A mechanistic link between renal ischemia and fibrosis.

Authors:  Tetsuhiro Tanaka
Journal:  Med Mol Morphol       Date:  2016-07-20       Impact factor: 2.309

10.  Rapamycin enhances cetuximab cytotoxicity by inhibiting mTOR-mediated drug resistance in mesenchymal hepatoma cells.

Authors:  Wei Chen; Qi-Da Hu; Xue-Feng Xia; Chao Liang; Hao Liu; Qi Zhang; Tao Ma; Feng Liang; Ting-Bo Liang
Journal:  Cancer Biol Ther       Date:  2014-05-06       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.